• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, June 26, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Good viruses and bad bacteria: A world-first green sea turtle trial

Bioengineer by Bioengineer
June 19, 2019
in Biology
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Bethany Keats, JCU Media

Researchers at the JCU Turtle Health Research Facility have conducted a first-of-its-kind study using what’s known as phage therapy as an option for bacterial infections in green sea turtles.

Phage therapy uses so-called ‘good viruses’ (bacteriophages) that occur naturally in the environment and kill bacteria.

“Green turtles rely on ‘good bacteria’ in their gut to extract nutrients from food,” said Dr Robert Kinobe, one of the researchers involved in the study.

“This creates a challenge when it comes to treating bacterial infections because if we administer antibiotics, it can destroy the ‘good bacteria’ and make the turtle’s health worse.”

Researchers at the JCU Turtle Health Research Facility applied ‘good viruses’ to green sea turtles and found that it was successful in eliminating the targeted ‘bad bacteria’ without hampering the non-targeted ‘good bacteria’.

“This shows that phage therapy can be safe and effective enough to manipulate or treat targeted bacteria in green sea turtles,” said Dr Kinobe.

A further complication, previously identified by the JCU Turtle Health Research Facility, is the existence of antibiotic-resistant bacteria in the guts of green sea turtles, which are found in several locations along the Queensland coast.

“Antimicrobial resistance is one of the most critical issues we face, which is why this finding of an alternative to antibiotics is so important,” said co-author Dr Lisa Elliott.

“Bacteriophages and phage therapy have already been suggested as an alternative for antibiotics in humans, but we also need to investigate its scope for treatment in animals.”

The research has been published in the Journal of Environmental Microbiology and opens the door for future applications of phage therapy as an alternative to antibiotics in treating bacterial infections in turtles and other marine animals.

###

Media Contact
Bethany Keats
[email protected]

Original Source

https://www.jcu.edu.au/news/releases/2019/june/good-viruses-and-bad-bacteria-a-world-first-green-sea-turtle-trial/

Related Journal Article

http://dx.doi.org/10.1111/1462-2920.14644

Tags: BacteriologyBiologyEcology/EnvironmentMarine/Freshwater BiologyVirologyZoology/Veterinary Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Natural Hallucinogens: Evolution’s Ecological Tools, Not Mere Chemical Byproducts

June 25, 2026

This Famous Butterfly Revealed: Three Distinct Species Hidden in One

June 25, 2026

Scientists Attack Soybean Cyst Nematode by Starving Its Food Source

June 25, 2026

Decoding the Secret Code of a Crucial Immune Sensor

June 24, 2026
Please login to join discussion

POPULAR NEWS

  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    92 shares
    Share 36 Tweet 23
  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tracking Lanthanide-Labeled Microplastics in Plants

POSTECH Researchers Slash Cost of Reconstituted Cell-Free Systems by 95%

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.